Allspring Global Investments
COGT icon

Allspring Global Investments’s Cogent Biosciences COGT Stock Holding History

Allspring Global Investments’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$565K Buy
14,673
+393
+3% +$13.8K ﹤0.01% 1416
2026
Q1 		$503K Buy
14,280
+3,755
+36% +$139K ﹤0.01% 1387
2025
Q4 		$366K Buy
+10,525
New +$296K ﹤0.01% 1465
2023
Q3 		– Sell
-434
Closed -$5.14K – 2807
2023
Q2 		$5.14K Sell
434
-92,246
-100% -$1.06M ﹤0.01% 2586
2023
Q1 		$1M Buy
92,680
+91,261
+6,431% +$1.17M ﹤0.01% 1414
2022
Q4 		$16.4K Sell
1,419
-32
-2% -$397 ﹤0.01% 2628
2022
Q3 		$21K Buy
+1,451
New +$19.9K ﹤0.01% 2608
2022
Q2 		– Sell
-799
Closed -$5K – 2735
2022
Q1 		$5K Sell
799
-93
-10% -$648 ﹤0.01% 2982
2021
Q4 		$7K Buy
+892
New +$7.75K ﹤0.01% 2926

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments's COGT Position: Q2 2026 in Review

Allspring Global Investments increased its Cogent Biosciences (COGT) stake by 2.8% in Q2 2026, buying an estimated $13.8K and bringing the position to 14,673 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Allspring Global Investments first reported a position in COGT in Q4 2021 and has held it in 9 quarters since. The position peaked at $1M in Q1 2023. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Allspring Global Investments held 14,673 shares of Cogent Biosciences worth $565K as of Q2 2026.
  • Allspring Global Investments bought 393 Cogent Biosciences shares in Q2 2026, an estimated $13.8K.
  • Cogent Biosciences made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1416 holding.
  • Allspring Global Investments first reported a position in Cogent Biosciences in Q4 2021 and has held it in 9 quarters since.
  • Allspring Global Investments's Cogent Biosciences position peaked at $1M in Q1 2023.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.